writes: An experimental treatment against an Ebola-related virus can protect monkeys even when given up to 3 days after infection, the point at which they show the first signs of disease. The virus, known as Marburg, causes severe hemorrhagic fever—vomiting, diarrhea, and internal bleeding. In one outbreak, it killed 90% of people it infected. There are no proven treatments or vaccines against it. The new results raise hopes that the treatment might be useful for human patients even if they don't receive it until well after infection. The company that makes the compound, Tekmira, based in Burnaby, Canada, has started a human safety trial of a related drug to treat Ebola virus disease, and researchers hope that it, too, might offer protection even after a patient has started to feel ill.
In other Ebola news, the two American aid workers who were infected with the virus while in Liberia have now recovered and been released from the hospital